Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common stock, $0.001 par value per share
-
Shares outstanding
-
12,986,368
-
Total 13F shares
-
14,904,350
-
Share change
-
+801,802
-
Total reported value
-
$1,321,835,128
-
Put/Call ratio
-
170%
-
Price per share
-
$88.67
-
Number of holders
-
130
-
Value change
-
+$76,412,905
-
Number of buys
-
75
-
Number of sells
-
49
Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) as of Q4 2015
As of 31 Dec 2015,
EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) was held by
130 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,904,350 shares.
The largest 10 holders included
ProQuest Associates IV LLC, Consonance Capital Management LP, JANUS CAPITAL MANAGEMENT LLC, JW Asset Management, LLC, Park West Asset Management LLC, Ranger Investment Management, L.P., Cormorant Asset Management, LLC, BlackRock Fund Advisors, STATE STREET CORP, and VANGUARD GROUP INC.
This page lists
130
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.